Topics

Global allergic rhinitis immunotherapy market set to reach $1.14bn by 2028, driven by growth in the US and Japan, says GlobalData

10:38 EDT 29 Oct 2019 | Pharmaceutical Technology

Allergic rhinitis (AR) is a common disease that causes sufferers to react adversely to otherwise innocuous inhaled substances. The most...
Read More...

The post Global allergic rhinitis immunotherapy market set to reach $1.14bn by 2028, driven by growth in the US and Japan, says GlobalData appeared first on Pharmaceutical Technology.

Original Article: Global allergic rhinitis immunotherapy market set to reach $1.14bn by 2028, driven by growth in the US and Japan, says GlobalData

NEXT ARTICLE

More From BioPortfolio on "Global allergic rhinitis immunotherapy market set to reach $1.14bn by 2028, driven by growth in the US and Japan, says GlobalData"

Quick Search

Relevant Topic

Allergies
The term allergy is used to describe a response, within the body, to a substance, which is not necessarily harmful in itself, but results in an immune response and a reaction that causes symptoms and disease in a predisposed person, which in turn can cau...